OR2AP1

Across TCGA pan-cancer cohorts, OR2AP1 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated OR2AP1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OR2AP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR2AP1 expression acts as an unfavorable survival marker.

BLCA, LUAD, and LUSC are the cancer types where OR2AP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.137	0.577	<.001	72	view →
LUAD	OS	Tertile	III,IV	0.053	0.661	<.001	48	view →
LUSC	OS	Tertile	III,IV	0.140	0.664	.016	36	view →
BRCA	OS	Tertile	All	0.130	0.579	.010	36	view →
KIRC	DFS	Tertile	IV	0.149	0.647	<.001	30	view →
LGG	DFS	Tertile	All	0.544	0.845	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OR2AP1–BLCA (DFS)

Open the BLCA breakdown →